Review and approve corporate goals and objectives relevant to the Chief Executive Officer’s compensation; in conjunction with the evaluation conducted by the Board as described in the Company’s Corporate Governance Guidelines, evaluate the Chief Executive Officer’s performance in light of these goals and objectives; and determine and approve (or determine and approve, and recommend to the independent members of the Board for their determination and approval) the Chief Executive Officer’s compensation level based on this evaluation and comparable market data provided by an independent compensation consultant Review and approve the compensation of other executive officers of the Company, including benefits and perquisites, taking into consideration the Company’s performance, comparable market data, the performance of each executive officer, and such other factors as may, in the Committee’s discretion, be appropriate

Review and approve a peer group of companies to be used for marketplace trend analysis and to assess the competitiveness of the Company’s total compensation opportunities for executive officers. 2 • Review and approve corporate goals and objectives relevant to the Chief Executive Officer’s compensation; in conjunction with the evaluation conducted by the Board (including as described in the Company’s Corporate Governance Guidelines), evaluate the Chief Executive Officer’s performance annually in light of these goals and objectives; and determine and recommend to the independent members of the Board for their determination and approval the Chief Executive Officer’s compensation level based on this evaluation and considering comparable market data provided by an independent compensation consultant Review and approve the compensation of other executive officers of the Company, including benefits and perquisites, taking into consideration the Company’s performance, comparable market data, the performance of each executive officer, and such other factors as may, in the Committee’s discretion, be appropriate

For more information, visit https://www.avient.com. In millions, except per share data) In millions, except per share data)

In millions, except per share data) In millions, except per share data) Photo - http://photos.prnewswire.com/prnh/20160425/359490

TECHNICAL PROPERTIES(1) TEST METHOD Edgetek™ ET8900-0011 HI UV NAT Edgetek™ ET8900-0012 HI UV White Edgetek™ ET8900-0013 HI UV Black Physical Density/Specific Gravity ASTM D792 1.13 g/cm3 1.15 g/cm3 1.13 g/cm3 Molding Shrinkage - Flow ASTM D955 1.4–2% 1.4–2% 1.4–2% Mechanical Tensile Strength (Yield) ASTM D638 5,900 psi 5,800 psi 5,800 psi Tensile Modulus(2) ASTM D638 169,000 psi 161,087 psi 176,000 psi Flexural Modulus(3) ASTM D790 187,000 psi 190,985 psi 188,000 psi Impact Notched Izod Impact 73°F (23°C), 0.125 in ASTM D256A 17.3 ft-lb/in 16.5 ft-lb/in 16.5 ft-lb/in Notched Izod Impact -22°F (-30°C), 0.125 in ASTM D256A 3.2 ft-lb/in 3.0 ft-lb/in 3.3 ft-lb/in Thermal (HDT) 66 psi (0.45 MPa), 0.125 in ASTM D648 121°C 135°C 129°C NORTH AMERICA GRADES (1) Data based on single lot of lab generated samples.

TECHNOLOGY COMPONENTS Select Rapid Color Prototyping Technology includes: Select Color Cell • Color scanning or matching • Creation of color plaques Online Software • Formulation and price generator • Web-based processor Automated Dispenser • Globally standard base colors • Consistent production from recipes HOW IT WORKS Select allows you to: • Instantaneously create a new color using your own standards, spectrophotometer or colorimeter data, or the software’s built-in design tools • Produce small quantities of color masterbatch for use in validating your color match • Combine advanced liquid colorants, cloud-access software and automated dispensing technology • Carry out color modeling and rapid iteration Select also helps you: • Choose the right color by providing a quick and cost effective way to model, sample, and test color options • Facilitate prototyping and variation testing PRODUCT BULLETIN CONVENTIONAL COLOR DEVELOPMENT PROCESS Multiple rounds of sampling, trials and approvals, usually over many weeks.

Data shows Capture does not affect the polyolefin stream even when it consists of 100% Capture closures.

TEMPERATURE DISTRIBUTION DIAGRAM • Test Method: FTTS-FA-010-2007 4.2 • Equipment: Thermovision • Heat Source: 500W Halogen Lamp • Heat Distance: 100 cm Surface temperature before exposure: 20.22°C Surface temperature after 10 min exposure: 33.85°C Temperature change: +13.6°C Added Cesa Fiber Additives for heat preservation TEST METHOD STANDARD REQUEST TEST RESULT GB/T30127 Far infrared radiation properties Far infrared emissivity ≥0.88 (5-14um) (Test temperature: 34°C) 0.9 Far infrared radiation temperature rise ≥ 1.4°C 9°C GB/T 18319-2019 Thermal retention with accumulated by infrared ray Maximum temperature rise ≥ 6°C 8.9°C Mean temperature rise ≥ 4.4°C (20 minutes) 5.6°C FTTS-FA-010 Infrared radiation properties & thermal retention temperature rise Average emissivity ≥ 0.8 (2-22um) (Test temperature: 25°C) 0.8 Specified heating ΔT ≥ 0.5°C (relative to the standard) +5.34°C (ΔT) GB/T 11048-2008 Method A Thermal transmittance Unit: clo Naked body: 0 Underwear: 0.04 T-shirt: 0.09 Thick sweater: 0.35 Winter coat: 0.7 All the data above are the reference value 0.625 Human Physiological Experiment Blood flow volume +12.9% Blood flow velocity +13.6% Blood oxygenation(%SpO2) +1.7% www.avient.com Copyright © 2023, Avient Corporation.

Additional information is available through the relevant Safety Data Sheet (SDS).

Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation Page 4 • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth • 17 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Steve Newlin Appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2013 2014 and beyond -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $38.38 March 7th, 2014 • 17 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 5 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% United States 66% Europe 14% Canada 7% Asia 6% Latin America 7% PP&S Specialty 53% Distribution 27% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target Ad ju st ed E ar ni ng s P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 6 PolyOne At A Glance Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty Specialty OI $5M $46M $87M $195M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 7 2006 2013 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.2% 12 – 16% Global Specialty Engineered Materials 1.1% 9.3% 12 – 16% Designed Structures & Solutions -- 5.6% 8 – 10% Performance Products & Solutions 5.4% 7.2% 9 – 12% Distribution 2.6% 5.9% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 62% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.1% 15% 4) Adjusted EPS Growth N/A 31% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 8 Bridge To $2.50 Adjusted EPS By 2015 2015 EPS: $2.50 2013 EPS: $1.31 Mid single digit revenue CAGR Page 9 Mergers & Acquisitions Spartech accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 10 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Healthcare Consumer Packaging and Additive Technology Transportation Page 11 Unique and Innovative Solutions that Help Customers Win https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG Net Debt / EBITDA* = 1.8x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of December 31, 2013 ($ millions) Page 12 Coupon Rates: 7.500% 7.375% 5.250% Debt Maturities & Pension Funding – 12/31/13 *TTM 12/31/2013 ** includes US-qualified plans only 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2013 Pension Funding** As of December 31, 2013 Free Cash Flow and Strong Balance Sheet Fund Investment •Targets that expand our: • Specialty offerings •End market presence •Geographic footprint •Operating Margin • Synergy opportunities •Adjacent material solutions •Expanding our sales, marketing, and technical capabilities • Investing in operational and LSS initiatives (including synergy capture) •Manufacturing alignment Organic Growth Share Repurchases Dividends Acquisitions Page 13 $0.16 $0.20 $0.24 $0.32 $0.00 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend • Repurchased ~5 million shares in 2013 • 15 million shares are available for repurchase under the current authorization The New PolyOne: A Specialty Growth Company 2015 Target: $2.50 Adjusted EPS Why Invest In PolyOne? Strong past performance demonstrates that our strategy and execution are working • Megatrends align with our strengths • Innovation and services provide differentiation, incremental pricing power, and competitive advantage • Strong and proven management team driving growth and performance • Addressable market exceeds $40 billion Page 14 1 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S.